Javascript must be enabled to continue!
Abstract 4773: MYC associated transcriptional heterogeneity at the single cell level
View through CrossRef
Abstract
Background:
Tumor heterogeneity allows cancer cells to adapt to microenvironmental stress and resist therapies. MYC is commonly amplified in human cancers and its expression can be heterogeneous due to variations in extrachromosomal DNA (ecDNA) and the pulsatile nature of MYC expression. However, the heterogeneity of the MYC responsive transcriptome among single cells is unknown. Here, we evaluate the heterogeneity of MYC transcriptional response in vitro in an inducible MYC cancer cell line.
Methods:
We used the P493-6 human B cell line model of Epstein-Barr Virus associated Burkitt’s lymphoma (BL) with tetracycline-repressible (Tet-OFF) ectopic MYC expression. We modulated MYC expression by addition of tetracycline and performed paired bulk and single-cell RNA-sequencing (scRNA-seq). To further characterize the transcriptional response of these cells with different MYC levels, we turned off MYC in these cells and then turned it back on to capture cells with increasing levels of MYC over time and performed paired bulk and single-cell RNA sequencing.
Results:
We observed heterogeneous expression of MYC and strikingly diverse expression of MYC responsive genes at the single cell level. After MYC induction with the removal of tetracycline, we observe a time-dependent decrease in STAT1 and other immune-related gene expression and movement of single cell transcriptomic clusters in high dimensional space visualized with tSNE plotting. Intriguingly, we observed a small cluster of CD58+ cells whose position in the tSNE space is unaltered by MYC status. We surmise that this cluster behaves like ‘stem’ cells capable of repopulating the entire population of P493 cells. Interestingly, we also see this small cluster of cells in some patient-derived BL cell lines.
Conclusions:
Overall, we provide detailed evidence of MYC driven transcriptional heterogeneity at the single cell level. Our preliminary evidence of this unique ‘stem-cell’ like population of cells in BL warrants further study.
Citation Format:
Saravana Gowtham Baskaran, Min-Zhi Jiang, Ada Tam, Hongkai Ji, Chi Van Dang. MYC associated transcriptional heterogeneity at the single cell level [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4773.
American Association for Cancer Research (AACR)
Title: Abstract 4773: MYC associated transcriptional heterogeneity at the single cell level
Description:
Abstract
Background:
Tumor heterogeneity allows cancer cells to adapt to microenvironmental stress and resist therapies.
MYC is commonly amplified in human cancers and its expression can be heterogeneous due to variations in extrachromosomal DNA (ecDNA) and the pulsatile nature of MYC expression.
However, the heterogeneity of the MYC responsive transcriptome among single cells is unknown.
Here, we evaluate the heterogeneity of MYC transcriptional response in vitro in an inducible MYC cancer cell line.
Methods:
We used the P493-6 human B cell line model of Epstein-Barr Virus associated Burkitt’s lymphoma (BL) with tetracycline-repressible (Tet-OFF) ectopic MYC expression.
We modulated MYC expression by addition of tetracycline and performed paired bulk and single-cell RNA-sequencing (scRNA-seq).
To further characterize the transcriptional response of these cells with different MYC levels, we turned off MYC in these cells and then turned it back on to capture cells with increasing levels of MYC over time and performed paired bulk and single-cell RNA sequencing.
Results:
We observed heterogeneous expression of MYC and strikingly diverse expression of MYC responsive genes at the single cell level.
After MYC induction with the removal of tetracycline, we observe a time-dependent decrease in STAT1 and other immune-related gene expression and movement of single cell transcriptomic clusters in high dimensional space visualized with tSNE plotting.
Intriguingly, we observed a small cluster of CD58+ cells whose position in the tSNE space is unaltered by MYC status.
We surmise that this cluster behaves like ‘stem’ cells capable of repopulating the entire population of P493 cells.
Interestingly, we also see this small cluster of cells in some patient-derived BL cell lines.
Conclusions:
Overall, we provide detailed evidence of MYC driven transcriptional heterogeneity at the single cell level.
Our preliminary evidence of this unique ‘stem-cell’ like population of cells in BL warrants further study.
Citation Format:
Saravana Gowtham Baskaran, Min-Zhi Jiang, Ada Tam, Hongkai Ji, Chi Van Dang.
MYC associated transcriptional heterogeneity at the single cell level [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4773.
Related Results
Abstract 4761: Investigation of the role of N-MYC in lung neuroendocrine carcinoma
Abstract 4761: Investigation of the role of N-MYC in lung neuroendocrine carcinoma
Abstract
Small cell lung cancer and large cell neuroendocrine carcinoma are classified as high-grade neuroendocrine tumors of the lung, representing extremely agg...
Improving immunotherapy in high-grade B-cell lymphoma
Improving immunotherapy in high-grade B-cell lymphoma
MYC is a transcription factor that upon deregulation acts as an oncogene. Cancer patients with MYC overexpression face significant worse outcomes to treatment with (immuno)chemothe...
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
Mantle cell lymphoma (MCL) with MYC rearrangement (MYC-R) is rare and little is known about the importance of MYC extra copies (EC) in the absence of MYC-R in MCL patients. This st...
Alternating cycles of quiescent and proliferative cell states determine stemness and leukemia-initiation capacity in acute lymphoblastic leukemia
Alternating cycles of quiescent and proliferative cell states determine stemness and leukemia-initiation capacity in acute lymphoblastic leukemia
Abstract
Background and significance. Stemness in acute myeloid leukemia (AML) is determined by a clonal hierarchy with ...
Flow Cytometry and Cytogenetics of Fine Needle Aspiration Biopsy Samples Is a Reliable Method for Diagnosing Burkitt Lymphoma. Evaluation of 78 Cases from a Single-Institution
Flow Cytometry and Cytogenetics of Fine Needle Aspiration Biopsy Samples Is a Reliable Method for Diagnosing Burkitt Lymphoma. Evaluation of 78 Cases from a Single-Institution
Abstract
Background: The diagnosis of Burkitt lymphoma (BL) is usually based on histopathology (HP), immunohistochemistry (IHC), fluorescence in situ hybridization (...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract
Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Abstract 1592: Pulsatile Myc expression as a source of Myc heterogeneity in cancer cells
Abstract 1592: Pulsatile Myc expression as a source of Myc heterogeneity in cancer cells
Abstract
Myc is the most commonly amplified oncogene, and is known to play critical roles in cancer establishment and maintenance. Myc expression heterogeneity has a...
Abstract PO-037: Machine learning-enabled transomics identifies three therapeutic targets for MYC-driven diffuse large B cell lymphoma
Abstract PO-037: Machine learning-enabled transomics identifies three therapeutic targets for MYC-driven diffuse large B cell lymphoma
Abstract
MYC activation and dysregulation is a powerful oncogenic driver in multiple cancers, including diffuse large B cell lymphoma (DLBCL). There is a known corre...

